Fidia S.p.A. (BIT: FDA)
Italy
· Delayed Price · Currency is EUR | Market Cap | 5.29M |
| Revenue | 28.74M |
| Net Income | -1.31M |
| Shares Out | 31.09M |
| EPS | -0.19 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,433,984 |
| Open | 0.193 |
| Previous Close | 0.190 |
| Day's Range | 0.166 - 0.193 |
| 52-Week Range | 0.166 - 1.340 |
| Beta | 0.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 11, 2024 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. Its accessories comprise HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; K5 tracer, a solution to perform continuous scanning of 3D surfaces; pushbutton panels; XPower digital drives for axis and spindle movement; and... [Read more]
News
Applied Therapeutics: Pushing Towards FDA Approval
Applied Therapeutics, Inc. is nearing FDA approval and potentially gaining another approval in 2025 for a different indication. Learn more on APLT stock here.
FDA cracks down on illegal sale of drugs
Pune: The Food and Drug Administration (FDA) of Maharashtra has initiated a statewide inspection drive to curb illegal sale of medicines by general pr.
Should You Continue to Retain PODD Stock in Your Portfolio Now?
Insulet Corp. 's (NASDAQ: PODD) recent FDA approval of Omnipod 5 for type 2 diabetes patients is set to expand the product's market potential. The planned launch of Omnipod 5 with Abbott's Freestyle ...
Expert Economist Slashes Hemp Acreage Forecast By 82% For 2030, Here's Why
As the hemp industry grapples with regulatory challenges, Whitney Economics has drastically cut its 2030 hemp acreage forecast . The revised projection now stands at just 1.0 million acres, a stark 82...
Inspire Medical Systems: Inspired, With Improving Risk-Reward (Rating Upgrade)
Inspire Medical Systems has shown impressive growth and recently obtained FDA approval for a new device. See why I upgrade INSP stock from hold to buy.
Peaking Back In On Intra-Cellular Therapies
Intra-Cellular Therapies is showing strong progress with potential FDA approval for CAPLYTA in major depressive disorder. Click here for my ITCI stock update.
Rare Disease-Focused Ascendis Pharma Stock Falls On Underwhelming Q2 Earnings, Guidance Cut
Tuesday, Ascendis Pharma A/S (NASDAQ: ASND) reported second-quarter sales of $38.76 million (35.9 million euros), missing the consensus of $92.7 million , down from 47.4 million euros reported a year...
Click Therapeutics Announces CT-132 Met Primary Endpoint for the Reduction of Monthly Migraine Days in ReMMi-D Pivotal Trial
The ReMMi-D trial evaluated the efficacy and safety of investigational prescription digital therapeutic CT-132 for the prevention of episodic migraine in patients 18 years and older, compared to a sha...
Axsome migraine therapy undergoes FDA review again
Denali to file for FDA accelerated approval of DNL310 in early 2025
BioVie gets FDA okay for Phase 2 study for long COVID drug
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-14127982881-8958fcf04ed6410fa3cc35dda54b701e.jpg)
Arrowhead Pharmaceuticals Stock Climbs on Plans To Seek FDA Approval for New Drug
Arrowhead Pharmaceuticals shares rose Tuesday after the company announced positive results in a late-stage study of its experimental treatment for a rare metabolic disorder, and said it plans to reque...
Embecta gets FDA clearance for type 2 diabetes patch pump
Zynex wins FDA nod for new pain management device
Zynex (ZYXI) receives FDA clearance for TensWave, a new pain management device using TENS therapy. Read more here.
FDA Approves Novavax's Updated COVID Vaccine Targeting Currently Circulating Variants
Friday, the FDA granted Emergency Use Authorization to Novavax Inc.’s (NASDAQ: NVAX) COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) for active immunization to prevent COVID-19 in indi...
FDA Approves Updated Novavax COVID Vaccine Week After Approving Moderna And Pfizers Shots
The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.
Eli Lilly Launches Discounted Mounjaro And Zepbound As Fight Against Compounded Imitations Escalates Amid Ongoing FDA Shortage Status Debate
Eli Lilly (NYSE: LLY) is intensifying its efforts to combat imitation versions of its popular appetite-suppressing drugs, Mounjaro and Zepbound. What Happened : The pharmaceutical giant is seeking to...
Biocon unit gets FDA nod for generic drug
Biocon's subsidiary has been granted approval by the US health regulator to market a generic medication for chronic heart failure treatment.
FDA approves updated Novavax COVID vaccine amid summer surge
The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID-19 vaccine amid the summer surge of infections. The new version of the vaccine “m...
Shilpa Medicare Stock: Share price surges 9% this week on USFDA approval for Bortezomib Injection
Following the company’s statement that the U.S. Food and Drug Administration (FDA) has approved its Bortezomib injection under New Drug Application (NDA) 212782, Shilpa Medicare Ltd.’s stock price inc...
Two separate graft cases filed against 3 govt officials
Anti-Corruption Bureau (ACB) in Thane takes swift action against corruption by registering two separate graft cases involving three government officials, including an assistant commissioner of FDA. Ca...
FDA authorizes Novavaxs updated Covid vaccine, paving way for fall rollout
The decision comes only a week after it approved a new round of messenger RNA shots from Pfizer and Moderna, which both target an offshoot of JN.1 called KP.2.
Novavax gains on FDA emergency nod for updated COVID shot
Novavax shares surge as FDA grants emergency use authorization for updated COVID-19 vaccine targeting Omicron variant JN.1 strain.
Gilead Sciences: Buy This Bargain Before It's Gone
Gilead Sciences, Inc. deserves a "Buy" rating as sales soar and new FDA approvals drive stock price growth in the pharmaceutical sector. Read more about GILD stock here.
Emergent BioSolutions Stock Storms Higher After The FDA Signs Off On Mpox Vaccine
The FDA approved a supplemental application to expand Emergent BioSolutions' existing smallpox vaccine to include Mpox.